Advertisement
Screener

ZIMMER BIOMET HOLDINGS, INC. (ZBH) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value

ZIMMER BIOMET HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value

ZIMMER BIOMET HOLDINGS, INC. (ZBH) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value of $108.83 per share as of 2025-12-31, per its 10-K filed 2026-02-20.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2026-02-20

  • 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $108.83.
  • 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $123.37.
  • 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $135.97.
  • 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $147.85.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair ValueShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value as first filed
2025-12-31$108.83
10-K · filed 2026-02-20
2024-12-31$123.37
10-K · filed 2026-02-20
2023-12-31$135.97
10-K · filed 2025-02-25
2022-12-31$147.85
8-K · filed 2024-08-07
2021-12-31$146.58
10-K · filed 2023-02-24
2020-12-31$129.65
8-K · filed 2022-06-22
2019-12-31$118.11
10-K · filed 2021-02-22
2018-12-31$112.81
10-K · filed 2020-02-21
2017-12-31$107.56
10-K · filed 2019-02-26
2016-12-31$102.04
10-K · filed 2018-02-27
2015-12-31$91.64
10-K · filed 2017-03-01
2014-12-31$76.60
10-K · filed 2016-02-29
2013-12-31$67.42
10-K · filed 2015-02-23
2012-12-31$61.11
10-K · filed 2014-02-28
$60.03
10-K · filed 2013-02-27
2011-12-31$56.25
10-K · filed 2013-02-27
2010-12-31$52.30
10-K · filed 2012-02-27
2009-12-31$42.09
10-K · filed 2011-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
STERIS plc (STE)Ireland$20.343B25.49
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B